Comment on: A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high-dose methotrexate therapy in open-label trials

被引:0
|
作者
Meyers, Paul A. [1 ,2 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10065 USA
关键词
D O I
10.1002/pbc.30617
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high-dose methotrexate therapy in open-label trials
    Janeway, Katherine A.
    Gros, Luis
    Schwartz, Stefan
    Daugherty, Claire
    Gallardo, Eva
    Hill, Christon
    Thomas, Emma
    Ward, Suzanne
    Rizzari, Carmelo
    PEDIATRIC BLOOD & CANCER, 2023, 70 (09)
  • [2] Reply to: Comment on: A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high-dose methotrexate therapy in open-label trials
    Janeway, Katherine A.
    Gros, Luis
    Schwartz, Stefan
    Daugherty, Claire
    Gallardo, Eva
    Hill, Christon
    Thomas, Emma
    Ward, Suzanne
    Rizzari, Carmelo
    PEDIATRIC BLOOD & CANCER, 2023, 70 (12)
  • [3] GLUCARPIDASE USE IN 86 PAEDIATRIC AND YOUNG ADULT PATIENTS RECEIVING HIGH-DOSE METHOTREXATE THERAPY: POOLED SUBGROUP ANALYSIS OF OPEN-LABEL TRIALS
    Janeway, Katherine
    Gros, Luis
    Schwartz, Stefan
    Daugherty, Claire
    Gallardo, Eva
    Hill, Christon
    Thomas, Emma
    Ward, Suzanne
    Rizzari, Carmelo
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [4] Rechallenge With High-Dose Methotrexate After Treatment With Glucarpidase in Adult Patients With Lymphoma
    Truong, Huong L.
    Barreto, Jason N.
    Mara, Kristin C.
    Hampel, Paul J.
    Micallef, Ivana N.
    Nowakowski, Grzegorz S.
    Thanarajasingam, Gita
    Thompson, Carrie A.
    Wang, Yucai
    Witzig, Thomas E.
    Herrmann, Sandra M.
    Leung, Nelson
    JCO ONCOLOGY PRACTICE, 2024, 20 (06) : 797 - 807
  • [5] Hispanic ethnicity as a risk factor for requiring glucarpidase rescue in pediatric patients receiving high-dose methotrexate
    Schafer, Eric S.
    Bernhardt, M. Brooke
    Reichert, Kate E.
    Haworth, Tara E.
    Shah, Mona D.
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (02) : E40 - E42
  • [6] Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I study
    Schaff, Lauren R.
    Lobbous, Mina
    Carlow, Dean
    Schofield, Ryan
    Gavrilovic, Igor T.
    Miller, Alexandra M.
    Stone, Jacqueline B.
    Piotrowski, Anna F.
    Sener, Ugur
    Skakodub, Anna
    Acosta, Edward P.
    Ryan, Kevin J.
    Mellinghoff, Ingo K.
    DeAngelis, Lisa M.
    Nabors, Louis B.
    Grommes, Christian
    BMC CANCER, 2022, 22 (01)
  • [7] Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I study
    Lauren R. Schaff
    Mina Lobbous
    Dean Carlow
    Ryan Schofield
    Igor T. Gavrilovic
    Alexandra M. Miller
    Jacqueline B. Stone
    Anna F. Piotrowski
    Ugur Sener
    Anna Skakodub
    Edward P. Acosta
    Kevin J. Ryan
    Ingo K. Mellinghoff
    Lisa M. DeAngelis
    Louis B. Nabors
    Christian Grommes
    BMC Cancer, 22
  • [8] Population pharmacokinetic analysis of high-dose methotrexate in pediatric and adult oncology patients
    Sonoko Kawakatsu
    Mina Nikanjam
    Mark Lin
    Sonny Le
    Ila Saunders
    Dennis John Kuo
    Edmund V. Capparelli
    Cancer Chemotherapy and Pharmacology, 2019, 84 : 1339 - 1348
  • [9] Population pharmacokinetic analysis of high-dose methotrexate in pediatric and adult oncology patients
    Kawakatsu, Sonoko
    Nikanjam, Mina
    Lin, Mark
    Le, Sonny
    Saunders, Ila
    Kuo, Dennis John
    Capparelli, Edmund V.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (06) : 1339 - 1348
  • [10] Glucarpidase (carboxypeptidase G2) intervention in adult and elderly cancer patients with renal dysfunction and delayed methotrexate elimination after high-dose methotrexate therapy
    Schwartz, Stefan
    Borner, Klaus
    Mueller, Krystina
    Martus, Peter
    Fischer, Lars
    Korfel, Agnieszka
    Auton, Timothy
    Thiel, Eckhard
    ONCOLOGIST, 2007, 12 (11): : 1299 - 1308